nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—GABRA3—Graves' disease	0.8	1	CbGaD
Triazolam—CYP2C9—Methimazole—Graves' disease	0.0346	0.632	CbGbCtD
Triazolam—CYP3A4—Methimazole—Graves' disease	0.0201	0.368	CbGbCtD
Triazolam—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00464	0.041	CbGpPWpGaD
Triazolam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00382	0.0338	CbGpPWpGaD
Triazolam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00377	0.0333	CbGpPWpGaD
Triazolam—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00356	0.0315	CbGpPWpGaD
Triazolam—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00352	0.0311	CbGpPWpGaD
Triazolam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00322	0.0284	CbGpPWpGaD
Triazolam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00313	0.0276	CbGpPWpGaD
Triazolam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00302	0.0267	CbGpPWpGaD
Triazolam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.003	0.0265	CbGpPWpGaD
Triazolam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00298	0.0263	CbGpPWpGaD
Triazolam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00294	0.026	CbGpPWpGaD
Triazolam—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00284	0.0251	CbGpPWpGaD
Triazolam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00284	0.0251	CbGpPWpGaD
Triazolam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00257	0.0227	CbGpPWpGaD
Triazolam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00234	0.0207	CbGpPWpGaD
Triazolam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00231	0.0204	CbGpPWpGaD
Triazolam—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00218	0.0193	CbGpPWpGaD
Triazolam—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00215	0.019	CbGpPWpGaD
Triazolam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00197	0.0174	CbGpPWpGaD
Triazolam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00191	0.0169	CbGpPWpGaD
Triazolam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00185	0.0163	CbGpPWpGaD
Triazolam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00184	0.0162	CbGpPWpGaD
Triazolam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0018	0.0159	CbGpPWpGaD
Triazolam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00158	0.014	CbGpPWpGaD
Triazolam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00158	0.0139	CbGpPWpGaD
Triazolam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00151	0.0133	CbGpPWpGaD
Triazolam—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.00151	0.0133	CbGpPWpGaD
Triazolam—GABRR3—eye—Graves' disease	0.0015	0.0965	CbGeAlD
Triazolam—GABRR2—eye—Graves' disease	0.0013	0.0837	CbGeAlD
Triazolam—GABRR1—eye—Graves' disease	0.00125	0.0806	CbGeAlD
Triazolam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00124	0.011	CbGpPWpGaD
Triazolam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.00122	0.0108	CbGpPWpGaD
Triazolam—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.00116	0.0102	CbGpPWpGaD
Triazolam—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.00114	0.0101	CbGpPWpGaD
Triazolam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.00105	0.00924	CbGpPWpGaD
Triazolam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00102	0.00897	CbGpPWpGaD
Triazolam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00098	0.00866	CbGpPWpGaD
Triazolam—GABRG3—pituitary gland—Graves' disease	0.000976	0.0627	CbGeAlD
Triazolam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000974	0.0086	CbGpPWpGaD
Triazolam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000956	0.00845	CbGpPWpGaD
Triazolam—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.00088	0.00777	CbGpPWpGaD
Triazolam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000836	0.00739	CbGpPWpGaD
Triazolam—GABRB1—pituitary gland—Graves' disease	0.000755	0.0485	CbGeAlD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000727	0.00642	CbGpPWpGaD
Triazolam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000724	0.0064	CbGpPWpGaD
Triazolam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000714	0.0063	CbGpPWpGaD
Triazolam—Hepatic failure—Propylthiouracil—Graves' disease	0.00071	0.0975	CcSEcCtD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000694	0.00613	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000694	0.00613	CbGpPWpGaD
Triazolam—Chlordiazepoxide—GABRA3—Graves' disease	0.000691	0.08	CrCbGaD
Triazolam—GABRA4—pituitary gland—Graves' disease	0.000681	0.0438	CbGeAlD
Triazolam—GABRP—pituitary gland—Graves' disease	0.000676	0.0434	CbGeAlD
Triazolam—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000675	0.00597	CbGpPWpGaD
Triazolam—Clonazepam—GABRA3—Graves' disease	0.000667	0.0773	CrCbGaD
Triazolam—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000667	0.00589	CbGpPWpGaD
Triazolam—TSPO—eye—Graves' disease	0.000649	0.0417	CbGeAlD
Triazolam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000647	0.00572	CbGpPWpGaD
Triazolam—TSPO—connective tissue—Graves' disease	0.000625	0.0402	CbGeAlD
Triazolam—Clotiazepam—GABRA3—Graves' disease	0.00062	0.0718	CrCbGaD
Triazolam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000617	0.00545	CbGpPWpGaD
Triazolam—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.000617	0.00545	CbGpPWpGaD
Triazolam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.00061	0.00539	CbGpPWpGaD
Triazolam—GABRA3—thyroid gland—Graves' disease	0.000602	0.0387	CbGeAlD
Triazolam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000592	0.00523	CbGpPWpGaD
Triazolam—GABRB3—eye—Graves' disease	0.000589	0.0379	CbGeAlD
Triazolam—Alprazolam—GABRA3—Graves' disease	0.000585	0.0678	CrCbGaD
Triazolam—Drowsiness—Methimazole—Graves' disease	0.000578	0.0794	CcSEcCtD
Triazolam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000572	0.00505	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000571	0.00505	CbGpPWpGaD
Triazolam—Cinolazepam—GABRA3—Graves' disease	0.00057	0.0661	CrCbGaD
Triazolam—GABRG2—pituitary gland—Graves' disease	0.00057	0.0366	CbGeAlD
Triazolam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000568	0.00502	CbGpPWpGaD
Triazolam—GABRB3—connective tissue—Graves' disease	0.000568	0.0365	CbGeAlD
Triazolam—Quazepam—GABRA3—Graves' disease	0.000567	0.0657	CrCbGaD
Triazolam—Jaundice—Methimazole—Graves' disease	0.000564	0.0774	CcSEcCtD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000563	0.00497	CbGpPWpGaD
Triazolam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000558	0.00493	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000547	0.00483	CbGpPWpGaD
Triazolam—Flunitrazepam—GABRA3—Graves' disease	0.000536	0.0621	CrCbGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000532	0.0047	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000526	0.00464	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000521	0.00461	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000521	0.00461	CbGpPWpGaD
Triazolam—GABRA2—adipose tissue—Graves' disease	0.000518	0.0333	CbGeAlD
Triazolam—GABRE—pituitary gland—Graves' disease	0.000516	0.0332	CbGeAlD
Triazolam—GABRE—adipose tissue—Graves' disease	0.000514	0.033	CbGeAlD
Triazolam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000508	0.00449	CbGpPWpGaD
Triazolam—Estazolam—GABRA3—Graves' disease	0.000501	0.0581	CrCbGaD
Triazolam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000501	0.00442	CbGpPWpGaD
Triazolam—Drowsiness—Propylthiouracil—Graves' disease	0.000492	0.0675	CcSEcCtD
Triazolam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000487	0.00431	CbGpPWpGaD
Triazolam—Halazepam—GABRA3—Graves' disease	0.000487	0.0564	CrCbGaD
Triazolam—TSPO—pituitary gland—Graves' disease	0.000482	0.031	CbGeAlD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000481	0.00425	CbGpPWpGaD
Triazolam—TSPO—adipose tissue—Graves' disease	0.00048	0.0308	CbGeAlD
Triazolam—Jaundice—Propylthiouracil—Graves' disease	0.000479	0.0658	CcSEcCtD
Triazolam—Adinazolam—GABRA3—Graves' disease	0.000477	0.0553	CrCbGaD
Triazolam—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000474	0.00418	CbGpPWpGaD
Triazolam—Fludiazepam—GABRA3—Graves' disease	0.000473	0.0547	CrCbGaD
Triazolam—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000468	0.00413	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000467	0.00413	CbGpPWpGaD
Triazolam—Prazepam—GABRA3—Graves' disease	0.000461	0.0534	CrCbGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000451	0.00398	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000448	0.00396	CbGpPWpGaD
Triazolam—GABRE—thyroid gland—Graves' disease	0.000445	0.0286	CbGeAlD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00044	0.00388	CbGpPWpGaD
Triazolam—GABRB3—pituitary gland—Graves' disease	0.000437	0.0281	CbGeAlD
Triazolam—Flurazepam—GABRA3—Graves' disease	0.00043	0.0498	CrCbGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000429	0.00379	CbGpPWpGaD
Triazolam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000428	0.00378	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000423	0.00374	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.000419	0.0037	CbGpPWpGaD
Triazolam—Oxazepam—GABRA3—Graves' disease	0.000416	0.0482	CrCbGaD
Triazolam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000416	0.00367	CbGpPWpGaD
Triazolam—TSPO—thyroid gland—Graves' disease	0.000415	0.0267	CbGeAlD
Triazolam—Temazepam—GABRA3—Graves' disease	0.000411	0.0476	CrCbGaD
Triazolam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000401	0.00354	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.0004	0.00354	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000399	0.00353	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000399	0.00353	CbGpPWpGaD
Triazolam—Midazolam—GABRA3—Graves' disease	0.000399	0.0462	CrCbGaD
Triazolam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000398	0.00352	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000395	0.00349	CbGpPWpGaD
Triazolam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000391	0.00346	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000384	0.0034	CbGpPWpGaD
Triazolam—GABRB3—thyroid gland—Graves' disease	0.000377	0.0242	CbGeAlD
Triazolam—Dysgeusia—Propylthiouracil—Graves' disease	0.000376	0.0517	CcSEcCtD
Triazolam—Oedema—Methimazole—Graves' disease	0.000369	0.0507	CcSEcCtD
Triazolam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000361	0.00319	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000351	0.0031	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000342	0.00302	CbGpPWpGaD
Triazolam—Diazepam—GABRA3—Graves' disease	0.000342	0.0396	CrCbGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000339	0.00299	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000337	0.00297	CbGpPWpGaD
Triazolam—Paraesthesia—Methimazole—Graves' disease	0.000331	0.0455	CcSEcCtD
Triazolam—CYP2C8—pituitary gland—Graves' disease	0.000331	0.0212	CbGeAlD
Triazolam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000331	0.00292	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000329	0.00291	CbGpPWpGaD
Triazolam—Somnolence—Methimazole—Graves' disease	0.000328	0.045	CcSEcCtD
Triazolam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000324	0.00286	CbGpPWpGaD
Triazolam—Oedema—Propylthiouracil—Graves' disease	0.000314	0.0431	CcSEcCtD
Triazolam—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000307	0.00271	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000303	0.00267	CbGpPWpGaD
Triazolam—CYP3A5—adipose tissue—Graves' disease	0.000297	0.0191	CbGeAlD
Triazolam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000289	0.00255	CbGpPWpGaD
Triazolam—Paraesthesia—Propylthiouracil—Graves' disease	0.000282	0.0387	CcSEcCtD
Triazolam—Somnolence—Propylthiouracil—Graves' disease	0.000279	0.0383	CcSEcCtD
Triazolam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000277	0.00245	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000269	0.00238	CbGpPWpGaD
Triazolam—Pruritus—Methimazole—Graves' disease	0.000261	0.0358	CcSEcCtD
Triazolam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.00026	0.00229	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000258	0.00228	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000253	0.00224	CbGpPWpGaD
Triazolam—Vomiting—Methimazole—Graves' disease	0.000235	0.0322	CcSEcCtD
Triazolam—Dermatitis—Methimazole—Graves' disease	0.000232	0.0319	CcSEcCtD
Triazolam—Headache—Methimazole—Graves' disease	0.000231	0.0317	CcSEcCtD
Triazolam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000225	0.00199	CbGpPWpGaD
Triazolam—Pruritus—Propylthiouracil—Graves' disease	0.000222	0.0305	CcSEcCtD
Triazolam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000221	0.00196	CbGpPWpGaD
Triazolam—Nausea—Methimazole—Graves' disease	0.000219	0.0301	CcSEcCtD
Triazolam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000215	0.0019	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000215	0.0019	CbGpPWpGaD
Triazolam—Vomiting—Propylthiouracil—Graves' disease	0.000199	0.0274	CcSEcCtD
Triazolam—Dermatitis—Propylthiouracil—Graves' disease	0.000198	0.0271	CcSEcCtD
Triazolam—Headache—Propylthiouracil—Graves' disease	0.000196	0.027	CcSEcCtD
Triazolam—Nausea—Propylthiouracil—Graves' disease	0.000186	0.0256	CcSEcCtD
Triazolam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000177	0.00156	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000174	0.00154	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000165	0.00146	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000163	0.00144	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000149	0.00132	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000145	0.00128	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00014	0.00123	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000139	0.00123	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000136	0.0012	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000119	0.00105	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GC—Graves' disease	7.75e-05	0.000685	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.92e-05	0.000611	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.31e-05	0.000557	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GC—Graves' disease	5.51e-05	0.000487	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	5.02e-05	0.000444	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—B3GNT2—Graves' disease	4.18e-05	0.000369	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GC—Graves' disease	3.99e-05	0.000352	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GC—Graves' disease	3.45e-05	0.000305	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—B3GNT2—Graves' disease	3.02e-05	0.000267	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GC—Graves' disease	2.81e-05	0.000248	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—B3GNT2—Graves' disease	2.62e-05	0.000231	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—B3GNT2—Graves' disease	2.13e-05	0.000188	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GC—Graves' disease	1.85e-05	0.000164	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.4e-05	0.000124	CbGpPWpGaD
